Recombinant Vaccines

Recombinant vaccines are vaccines developed using genetic engineering techniques. They use recombinant DNA to create a vaccine that is more effective at inducing an immune response. Recombinant vaccines are used to protect against a wide range of diseases, including influenza, hepatitis, diphtheria, measles, HPV, and rotavirus. They are often safer and more effective than traditional vaccines, as they target specific antigens and are not weakened or inactivated by the manufacturing process. Additionally, they are less likely to cause side effects or cause an allergic reaction. As such, these vaccines can be used in a variety of populations, including infants, the elderly, and those with compromised immune systems. Recombinant vaccines have the potential to save millions of lives, improving human health and well-being around the world.

← Journal of Current Viruses and Treatment Methodologies

Related Articles

3 article(s) found

Dynamics of Infections and Number of Vaccines Needed to Avoid Covid-19 in Europe

Full-text HTML Download PDF Download XML

FDA Should Re-evaluate All mRNA Vaccines and Revoke Their Use Authorizations (The Short Version).

Full-text HTML Download PDF Download XML

Expression of Concern: Potential Risks and Unknown Effects of mRNA Vaccines on Population Health (6th Rev). Damages Are Being Materialized

Full-text HTML Download PDF Download XML